← SynDRA
BMS-833923
SynDRA canonical compound SYN0038295 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | DHH | IHH | SMO |
| Mechanism of action | smoothened receptor antagonist |
All known targets
Mechanisms of action (all sources)
- SMO ANTAGONIST
- Smoothened homolog antagonist
- smoothened receptor antagonist
- SMO INHIBITOR
Cross-references
Synonyms
- BMS-833923 DIMESYLATE MONOHYDRATE
- BMS-833923 FREE BASE ANHYDROUS
- XL-139
- XL139
- BMS 833923
- BMS833923
- UNII-41J7ZJ239R
- N-(2-Methyl-5-((methylamino)methyl)phenyl)-4-((4-phenylquinazolin-2-yl)amino)benzamide
- 41J7ZJ239R
- C30H27N5O
- N-(2-methyl-5-((methylamino)methyl)phenyl)-4-(4-phenylquinazolin-2-ylamino)benzamide
- Benzamide, N-[2-methyl-5-[(methylamino)methyl]phenyl]-4-[(4-phenyl-2-quinazolinyl)amino]-
- BMS-833923 free base anhydrous
- XL139 mesylate
- SCHEMBL4138073
- GTPL8202
- CHEMBL3545403
- EX-A789
- MolPort-035-395-837
- HMS3653O09
- BCP07837
- AOB87352
- XL 139
- RefChem:120750
- BMS-833923 (XL-139)
- MFCD25976660
- Bms-833923 dimesylate monohydrate
- orb1305757
- SCHEMBL29493087
- GLXC-90164
- JSB73466
- NSC781469
- s7138
- BMS-833923 [WHO-DD]
- AKOS026750412
- CCG-264699
- CS-1464
- NSC-781469
Look up BMS-833923 in the interactive SynDRA portal →